{"abstract": "Sanofi-Aventis has agreed to buy the private U.S. cancer specialist BiPar Sciences for up to $500 million, in the latest bolt-on acquisition by the French drugmaker.", "web_url": "https://dealbook.nytimes.com/2009/04/15/sanofi-buys-us-cancer-firm-for-up-to-500-million/", "snippet": "", "lead_paragraph": "Sanofi-Aventis has agreed to buy the private U.S. cancer specialist BiPar Sciences for up to $500 million, in the latest bolt-on acquisition by the French drugmaker.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi Buys U.S. Cancer Firm for Up to $500 Million", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-04-15T11:05:42+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/1e07b572-16e7-5b0a-bc87-7c792c68b11f", "word_count": 342, "uri": "nyt://article/1e07b572-16e7-5b0a-bc87-7c792c68b11f"}